Long-term data back UAE (uterine artery embolisation) Embosphere therapy:
This article was originally published in Clinica
BioSphere Medical has reported positive results from what it claims is the first study to assess the long-term safety and efficacy of its Embosphere microspheres in the treatment of uterine artery embolisation (UAE). A follow-up at one, six and 12-months of 20 patients who received the treatment showed that symptoms of severe bleeding were resolved in 19 of them and improved in the 20th patient, revealed data from a European study. The Rockland, Massachusetts company markets the microspheres for general embolisation therapy in Europe, where they are also available for UAE therapy, and in the US.